Live Breaking News & Updates on Structure Therapeutics|Page 1

Stay updated with breaking news from Structure therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Gilead Stock Jumps After Its Weight-Loss Drug Emerges From Under The Radar

Gilead stock jumped Friday after surprising Wall Street with preclinical test results for an under-the-radar weight-loss drug. ....

United States , Eli Lilly , Novo Wegovy , Lilly Zepbound , Gilead Sciences , Goldman Sachs , American Diabetes Association , Wall Street , Umer Raffat , Structure Therapeutics , Huge Weight Loss Drugs , Novo Nordisk ,

Avoro Capital Advisors LLC Grows Stake in Structure Therapeutics Inc. (NASDAQ:GPCR)

Avoro Capital Advisors LLC raised its position in shares of Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) by 133.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,333,333 shares of the company’s stock after buying an additional 1,333,333 shares during the […] ....

New Zealand General , New Zealand , Cantor Fitzgerald , Exchange Commission , Capital International Investors , Jpmorgan Chase Co , Avoro Capital Advisors , Hermes Inc , Capital Research Global Investors , Wellington Management Group , Structure Therapeutics Inc , Structure Therapeutics , Free Report , Capital Advisors , Capital Partners , International Investors , Management Group , Research Global Investors , Lifesci Capital , Get Free Report , Therapeutics Inc , Visit Holdingschannel , Structure Therapeutics Daily ,

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares - Structure Therapeutics (NASDAQ:GPCR)

SAN FRANCISCO, June 07, 2024 (GLOBE NEWSWIRE) Structure Therapeutics Inc. (NASDAQ:GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and ....

New York , United States , Danielle Keatley , Exchange Commission , Syndicate Department , Equity Syndicate Prospectus Department , Morgan Stanley , Goldman Sachs Co , Equity Syndicate Department , Morgan Stanley Co , Prospectus Department , Structure Therapeutics Inc , Capital Markets Corp , Guggenheim Securities , Structure Therapeutics , Leerink Partners , Markets Corp ,

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares

Structure Therapeutics Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional American Depositary Shares
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United States , New York , Danielle Keatley , Dan Budwick , Capital Markets Corp , Morgan Stanley Co , Equity Syndicate Prospectus Department , Syndicate Department , Guggenheim Securities , Morgan Stanley , Structure Therapeutics Inc , Equity Syndicate Department , Exchange Commission , Goldman Sachs Co , Prospectus Department , Therapeutics Announces Closing , Upsized Public Offering , Full Exercise , Underwriter Option , Purchase Additional American Depositary , Structure Therapeutics , Leerink Partners , Markets Corp ,

Structure Therapeutics Announces Pricing of Upsized $476 Million Public Offering

SAN FRANCISCO, June 05, 2024 Structure Therapeutics Inc. , a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic and cardiopulmonary. ....

United States , New York , Dan Budwick , Danielle Keatley , Equity Syndicate Prospectus Department , Morgan Stanley Co , Syndicate Department , Equity Syndicate Department , Structure Therapeutics Inc , Guggenheim Securities , Exchange Commission , Capital Markets Corp , Morgan Stanley , Prospectus Department , Goldman Sachs Co , Structure Therapeutics , Leerink Partners , Markets Corp , Private Securities Litigation Reform Act , Annual Report , Quarterly Report ,